The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis

Breast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the...

Full description

Bibliographic Details
Main Authors: Justina Bekampytė, Agnė Bartnykaitė, Aistė Savukaitytė, Rasa Ugenskienė, Erika Korobeinikova, Jurgita Gudaitienė, Elona Juozaitytė
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Diagnostics
Subjects:
SNP
Online Access:https://www.mdpi.com/2075-4418/11/8/1419
id doaj-905692a5b9a64961ba69b088fa6aa49b
record_format Article
spelling doaj-905692a5b9a64961ba69b088fa6aa49b2021-08-26T13:40:18ZengMDPI AGDiagnostics2075-44182021-08-01111419141910.3390/diagnostics11081419The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and PrognosisJustina Bekampytė0Agnė Bartnykaitė1Aistė Savukaitytė2Rasa Ugenskienė3Erika Korobeinikova4Jurgita Gudaitienė5Elona Juozaitytė6Oncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaOncology Research Laboratory, Oncology Institute, Lithuanian University of Health Sciences, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaDepartment of Oncology and Hematology, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, LT-50161 Kaunas, LithuaniaBreast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the roles of single nucleotide polymorphisms (SNPs) in these genes have not been fully defined. Therefore, this study aimed to analyze the association between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344 and <i>EGFR</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis. For the purpose of the analysis, 171 Lithuanian women were enrolled. Genomic DNA was extracted from peripheral blood; PCR-RFLP was used for SNPs analysis. The results showed that <i>BBC3</i> rs2032809 was associated with age at the time of diagnosis, disease progression, metastasis and death. <i>CCND1</i> rs9344 was associated with tumor size, however an association resulted in loss of significance after Bonferroni correction. In survival analysis, significant associations were observed between <i>BBC3</i> rs2032809 and OS, PFS and MFS. <i>EGFR</i> rs2227983 also showed some associations with OS and PFS (univariate Cox regression analysis). However, the results were in loss of significance (multivariate Cox regression analysis). In conclusion, <i>BBC3</i> rs2032809 polymorphism was associated with breast cancer phenotype and prognosis. Therefore, it could be applied as potential markers for breast cancer prognosis.https://www.mdpi.com/2075-4418/11/8/1419breast cancerSNP<i>TP53</i><i>BBC3</i><i>CCND</i><i>EGFR</i>
collection DOAJ
language English
format Article
sources DOAJ
author Justina Bekampytė
Agnė Bartnykaitė
Aistė Savukaitytė
Rasa Ugenskienė
Erika Korobeinikova
Jurgita Gudaitienė
Elona Juozaitytė
spellingShingle Justina Bekampytė
Agnė Bartnykaitė
Aistė Savukaitytė
Rasa Ugenskienė
Erika Korobeinikova
Jurgita Gudaitienė
Elona Juozaitytė
The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
Diagnostics
breast cancer
SNP
<i>TP53</i>
<i>BBC3</i>
<i>CCND</i>
<i>EGFR</i>
author_facet Justina Bekampytė
Agnė Bartnykaitė
Aistė Savukaitytė
Rasa Ugenskienė
Erika Korobeinikova
Jurgita Gudaitienė
Elona Juozaitytė
author_sort Justina Bekampytė
title The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
title_short The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
title_full The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
title_fullStr The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
title_full_unstemmed The Investigation of Associations between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344, <i>EGFR</i> rs2227983 Polymorphisms and Breast Cancer Phenotype and Prognosis
title_sort investigation of associations between <i>tp53</i> rs1042522, <i>bbc3</i> rs2032809, <i>ccnd1</i> rs9344, <i>egfr</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-08-01
description Breast cancer is one of the most common oncological diseases among women worldwide. Cell cycle and apoptosis—related genes <i>TP53</i>, <i>BBC3</i>, <i>CCND1</i> and <i>EGFR</i> play an important role in the pathogenesis of breast cancer. However, the roles of single nucleotide polymorphisms (SNPs) in these genes have not been fully defined. Therefore, this study aimed to analyze the association between <i>TP53</i> rs1042522, <i>BBC3</i> rs2032809, <i>CCND1</i> rs9344 and <i>EGFR</i> rs2227983 polymorphisms and breast cancer phenotype and prognosis. For the purpose of the analysis, 171 Lithuanian women were enrolled. Genomic DNA was extracted from peripheral blood; PCR-RFLP was used for SNPs analysis. The results showed that <i>BBC3</i> rs2032809 was associated with age at the time of diagnosis, disease progression, metastasis and death. <i>CCND1</i> rs9344 was associated with tumor size, however an association resulted in loss of significance after Bonferroni correction. In survival analysis, significant associations were observed between <i>BBC3</i> rs2032809 and OS, PFS and MFS. <i>EGFR</i> rs2227983 also showed some associations with OS and PFS (univariate Cox regression analysis). However, the results were in loss of significance (multivariate Cox regression analysis). In conclusion, <i>BBC3</i> rs2032809 polymorphism was associated with breast cancer phenotype and prognosis. Therefore, it could be applied as potential markers for breast cancer prognosis.
topic breast cancer
SNP
<i>TP53</i>
<i>BBC3</i>
<i>CCND</i>
<i>EGFR</i>
url https://www.mdpi.com/2075-4418/11/8/1419
work_keys_str_mv AT justinabekampyte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT agnebartnykaite theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT aistesavukaityte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT rasaugenskiene theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT erikakorobeinikova theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT jurgitagudaitiene theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT elonajuozaityte theinvestigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT justinabekampyte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT agnebartnykaite investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT aistesavukaityte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT rasaugenskiene investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT erikakorobeinikova investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT jurgitagudaitiene investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
AT elonajuozaityte investigationofassociationsbetweenitp53irs1042522ibbc3irs2032809iccnd1irs9344iegfrirs2227983polymorphismsandbreastcancerphenotypeandprognosis
_version_ 1721194041283969024